SEC Tracker
Get the app

Guardant Health GH

Meghan V. Joyce (Director) plans to sell 3,337 GH shares, about $157,573

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Jun 13, 2025
  2. Broker: Charles Schwab & Co., Inc.
  3. Shares acquired by: Restricted Stock Lapse - see remarks
  4. 10b5-1 plan adopted: Aug 13, 2024

All of Meghan V. Joyce's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Guardant Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Lumexa Imaging Holdings LMRI
  2. RadNet RDNT public float $4.1B, Jun 30, 2025
  3. Caris Life Sciences CAI public float $3.9B, Jun 30, 2025
  4. Exact Sciences EXAS public float $10.0B, Jun 30, 2025
  5. BillionToOne BLLN

Data on this page was fetched . The filing on SEC.gov is the record.